A risk model allowing cardiologists and their patients to share decision-making about undergoing surgery after transcatheter aortic valve replacement (TAVR) had received high marks for its accuracy in ...

A simpler alternative to open heart surgery is gaining popularity, but some find ​their new valves don’t last as long as they ...

CHICAGO — Five years after treatment, patients with severe aortic stenosis had comparable rates of all-cause mortality or disabling stroke, whether they received transcatheter aortic valve replacement ...

Please provide your email address to receive an email when new articles are posted on . In younger patients with severe aortic stenosis and low surgical risk, TAVR had similar 1-year outcomes as ...

Please provide your email address to receive an email when new articles are posted on . In patients with severe aortic stenosis at low surgical risk, TAVR appears to be just as beneficial as surgery.

Two new observational studies suggest GLP-1 receptor agonists may reduce cardiovascular risks after transcatheter aortic valve replacement (TAVR) and carotid artery stenting (CAS). Tirzepatide use ...

SAN FRANCISCO -- Long-term outcomes after transcatheter aortic valve replacement (TAVR) were looking more and more like those after surgical aortic valve replacement (SAVR) in low-risk patients, ...

SAN FRANCISCO -- A handful of years later, transcatheter aortic valve replacement (TAVR) still compared well against surgery in the PARTNER 3 and Evolut Low Risk trials. PARTNER 3 appeared to show a ...

The number of deaths and disabling strokes among patients at low surgical risk who were treated with transcatheter aortic valve replacement (TAVR) remained lower at three years, but not significantly ...

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...

Intermediate-risk patients who received transcatheter aortic valve replacement, known as TAVR, with the latest-generation valve fared better than patients receiving traditional surgical aortic valve ...

Cardiothoracic Surgeon Geoffrey R. Cousins, MD, FACS, left, and Interventional Cardiologist Jason Schott, DO, mark the 100th transcatheter aortic valve replacement procedure performed at Memorial ...